LabCompass

Shay Bracha

Medicine · The Ohio State University

OpenAlex ORCID
Veterinary Oncology ResearchExtracellular vesicles in diseaseVeterinary Medicine and SurgeryNanoplatforms for cancer theranosticsVirus-based gene therapy research

Publications

60

Citations

914

Est. group size

—

Recurring co-author estimate

Active years

18

Publishing since 2009

Research summary
AI-generated

Shay Bracha's research focuses on veterinary cancer biology, particularly in dogs, using naturally occurring canine tumors (such as osteosarcoma, mammary cancer, lymphoma, and soft tissue sarcoma) as models that may also inform human cancer research. The work combines tools like extracellular vesicles (tiny cell-released particles that can carry disease-related molecules), proteomics (large-scale protein analysis), immune profiling, and novel therapies including electroporation-based tumor ablation and antibody-based immunotherapy.

Veterinary oncology (canine cancer models)Extracellular vesicles and liquid biopsy diagnosticsCancer immunotherapy and immune profilingProteomics of drug resistance in tumorsTumor ablation techniques (electroporation)

Publication output has declined from a peak in 2017 to a lower, fluctuating pace in recent years, averaging about 3.6 papers per year over the last five years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 3.6/year recently
2017: 10 publications10172018: 5 publications182019: 3 publications192020: 6 publications202021: 3 publications212022: 2 publications222023: 5 publications232024: 6 publications242025: 4 publications252026: 1 publication26
Recent publications
Publishes in
  • Veterinary Surgery×3
  • Cancer Research×3
  • Small×2
  • Scientific Reports×2
  • Veterinary and Comparative Oncology×2

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile